Skip to content

Study · Measured the body's own peptide · 2010

1 result

Differential induction of cellular proliferation, hypertrophy and apoptosis in H9c2 cardiomyocytes by exogenous tissue factor.

Alkistis Frentzou G, Collier ME, Seymour AM, Ettelaie C

Molecular and cellular biochemistry22 Aug 2010Cited by 12 (Europe PMC)

PMID20730477 (opens in a new tab)DOI10.1007/s11010-010-0565-8 (opens in a new tab)PepBankPUB-20730477
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01LabEndogenous levelIn vitro (cells)Mechanism

    In rat H9c2 cardiomyocytes, exposure to recombinant tissue factor increased natural MGF expression, most at an intermediate concentration (13 ng/ml).

    In plain wordsIn rat heart cells, tissue factor raised the cells' own MGF, most at an intermediate dose.

    Peptide
    MGF / PEG-MGF
    Outcome
    IncreaseMGF expression after tissue factor exposure
    Study

    ratn: not reported in source

    H9c2 cardiomyocytes
    Outcome group
    Heart function · Cardiovascular

    Source sentences

    Summary
    Incubation of cells with rTF resulted in enhanced expression of MGF particularly at the intermediate concentrations of rTF (13 ng/ml)
    1 context sentence
    Summary · context
    H9c2 rat cardiomyocytes were exposed to a range of concentrations of recombinant TF (rTF) (1.3-52 ng/ml) for up to 10 days and the outcome on cell proliferation and induction of apoptosis measured.

    This result measures the body's own MGF / PEG-MGF. Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.